논문실적
Home › 연구실적 › 논문실적
- 275Genotype-based enrichment study design for minimizing the sample size in bioequivalence study: Tolterodine and CYP2D6 genotype
Oh M, Yeo CW, Kim HS, Shon JH, Shin JG · Int J Clin Pharmacol Ther. 57(2):110-116 / 2019.02 · 2019 cPMTb
- 274What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing.
Polasek TM, Rostami-Hodjegan A, Yim DS, Jamei M, Lee H, Kimko H, Kim JK, Nguyen PTT, Darwich AS, Shin JG · AAPS J. 9;21(2):17 / 2019.01 · 2019 cPMTb
- 273Inhibitory effects of Kampo medicines, Keishibukuryogan and Shakuyakukanzoto, on the substrate uptake activities of solute carrier organic anion transporters.
Lee HS, Shin HJ, Cho MJ, Lee SH, Oh DS · J Pharmacol Sci. 138(4):279-283 / 2018.12 · 2018 cPMTb
- 272Pharmacodynamic effects of voglibose administered alone, administered with metformin and administered with metformin in a fixed-dose combination in healthy Korean subjects
Kim HS, Oh MK, Kim EJ, Song GS, Kim EY, Shin JG · Int J Clin Pharmacol Ther. 56(11):544-550 / 2018.11 · 2018 cPMTb
- 271Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin -Containing Monooxygenase 3 Maturational Changes Over Time
Nguyen PTT, Parvez MM, Kim MJ, Lee JH, Ahn SZ, Ghim JL, Shin JG · J Clin Pharmacol. 58(10):1347-1360 / 2018.10 · 2018 cPMTb
- 270Comprehensive substrate characterization of 22 antituberculosis drugs for multiple solute carrier (SLC) uptake transporters, in vitro
Parvez MM, Kaisar N, Shin HJ, Lee YJ, Shin JG · Antimicrob Agents Chemother. 27;62(9):e00512-18 / 2018.08 · 2018 cPMTb
- 269Genetic analysis of sick sinus syndrome in a family harboring compound CACNA1C and TTN mutations
Zhu YB, Luo JW, Jiang F, Liu G · Mol Med Rep. 17(5):7073-7080 / 2018.05 · 2018 cPMTb
- 268Identification and characterization of amiodarone metabolites in rats using UPLC-ESI-QTOFMS-based untargeted metabolomics approach
Jeong ES, Kim GB, Yim DE, Moon KS, Lee SJ, Shin JG, Kim DH · J Toxicol Environ Health A. 81(12):481-492 / 2018.05 · 2018 cPMTb
- 267Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects
Oh MK, Ghim JL, Park SE, Kim EY, Shin JG · Drug Des Devel Ther. 8:12:1157-1164 / 2018.05 · 2018 cPMTb
- 266Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical endpoints - Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)
Bergmeijer TO, ~, Shin JG, ~ Shuldiner AR; ICPC Investigators. · Am Heart J. 198:152-159 / 2018.04 · 2018 cPMTb
- 265Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE)
Kim WY, Lee SJ, Min JK, Oh KS, Kim DH, Kim HS, Shin JG. · Prostaglandins Leukot Essent Fatty Acids. 131:6-13 / 2018.04 · 2018 cPMTb
- 264Prognostic significance of hypoxia inducible factor-1α expression in patients with clear cell renal cell carcinoma.
Wu S, Jiang F, Wu H, Wang Y, Xu R, Cao J, Lu Q, Zhu X, Zhong Z, Zhao X · Mol Med Rep. 17(3):4846-4852 / 2018.03 · 2018 cPMTb
- 263Stereoselectivity in the cytochrome P450-dependent N-demethylation and flavin monooxygenase-dependent N-oxidation of N,N-dimethylamphetamine.
Lee S, Yoo HH, In MK, Jin C, Kim DH. · Arch Pharm Res. 36(11):1385-91 / 2013.11 · 2013-International PRCDM
- 262CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina.
Kim HS, Chang K, Koh YS, Park MW, Choi YS, Park CS, Oh M, Kim EY, Shon JH, Shin JG, Seung KB. · Circ Cardiovasc Genet. 6(5):514-21 / 2013.10 · 2013-International BMRC, PRCDM
- 261Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary intervention.
Park MW, Her SH, Kim HS, Choi YS, Park CS, Koh YS, Park HJ, Kim PJ, Kim CJ, Jeon DS, Shin DI, Seo SM, Yoo KD, Kim DB, Kim HY, Lee JM, Chung WS, Seung KB, Shin JG, Chang K. · Pharmacogenet Genomics. 23(10):558-62 / 2013.10 · 2013-International PRCDM